These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2703530)
1. Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs. Maturi MF; Greene R; Speir E; Burrus C; Dorsey LM; Markle DR; Maxwell M; Schmidt W; Goldstein SR; Patterson RE J Clin Invest; 1989 Apr; 83(4):1217-24. PubMed ID: 2703530 [TBL] [Abstract][Full Text] [Related]
2. Functional consequences and intracoronary localization of alpha-adrenergic stimulation of the canine coronary circulation. Maturi MF; Greene R; Donohue B; Dorsey LM; Green MV; Bacharach SL; Vitale D; Patterson RE J Am Coll Cardiol; 1986 Oct; 8(4):885-93. PubMed ID: 2876017 [TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y (NPY): a coronary vasoconstrictor and potentiator of catecholamine-induced coronary constriction. Macho P; Pérez R; Huidobro-Toro JP; Domenech RJ Eur J Pharmacol; 1989 Aug; 167(1):67-74. PubMed ID: 2776842 [TBL] [Abstract][Full Text] [Related]
4. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina. Rosano GMC; Tousoulis D; McFadden E; Clarke J; Davies GJ; Kaski JC Int J Cardiol; 2017 Jul; 238():123-127. PubMed ID: 28476516 [TBL] [Abstract][Full Text] [Related]
5. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Maturi MF; Martin SE; Markle D; Maxwell M; Burruss CR; Speir E; Greene R; Ro YM; Vitale D; Green MV Circulation; 1991 Jun; 83(6):2111-21. PubMed ID: 1904014 [TBL] [Abstract][Full Text] [Related]
6. Effect of nifedipine on neuropeptide Y-induced coronary vasoconstriction in anesthetized dogs. Hayashi M; Aizawa Y; Satoh M; Suzuki K; Shibata A Jpn Heart J; 1986 Mar; 27(2):251-7. PubMed ID: 3755186 [TBL] [Abstract][Full Text] [Related]
7. Adenosine receptor blockade with 8-p-sulfophenyltheophylline aggravates coronary constriction. Martin SE; Tidmore WC; Patterson RE Am J Physiol; 1991 Jun; 260(6 Pt 2):H1753-9. PubMed ID: 2058714 [TBL] [Abstract][Full Text] [Related]
8. Effects of neuropeptide Y on regulation of blood flow rate in canine myocardium. Svendsen JH; Sheikh SP; Jørgensen J; Mikkelsen JD; Paaske WP; Sejrsen P; Haunsø S Am J Physiol; 1990 Dec; 259(6 Pt 2):H1709-17. PubMed ID: 2260698 [TBL] [Abstract][Full Text] [Related]
9. Neuropeptide-Y causes coronary microvascular constriction and is associated with reduced ejection fraction following ST-elevation myocardial infarction. Herring N; Tapoulal N; Kalla M; Ye X; Borysova L; Lee R; Dall'Armellina E; Stanley C; Ascione R; Lu CJ; Banning AP; Choudhury RP; Neubauer S; Dora K; Kharbanda RK; Channon KM; Eur Heart J; 2019 Jun; 40(24):1920-1929. PubMed ID: 30859228 [TBL] [Abstract][Full Text] [Related]
10. Potency and receptors involved in coronary vasoconstriction caused by neuropeptide Y(NPY). Aizawa Y; Satoh M; Aizawa M; Funazaki T; Niwano S; Miyajima S; Shibata A Jpn Heart J; 1987 Nov; 28(6):891-8. PubMed ID: 2832630 [TBL] [Abstract][Full Text] [Related]
11. Attenuation of the vasoconstrictor action of neuropeptide-Y by calcium-channel blockers. Aizawa Y; Niwano S; Aizawa M; Tamura M; Shibata A Angiology; 1989 Oct; 40(10):890-4. PubMed ID: 2802259 [TBL] [Abstract][Full Text] [Related]
12. Coronary constriction due to neuropeptide Y: alleviation with cyclooxygenase blockers. Martin SE; Patterson RE Am J Physiol; 1989 Sep; 257(3 Pt 2):H927-34. PubMed ID: 2506768 [TBL] [Abstract][Full Text] [Related]
13. Haemodynamic effects of intracoronary neuropeptide Y in dogs: resistance to alpha adrenergic blockade. Stack RK; Patterson RE Cardiovasc Res; 1991 Sep; 25(9):757-63. PubMed ID: 1666019 [TBL] [Abstract][Full Text] [Related]
14. Vasoconstrictor effect of neuropeptide Y (NPY) on canine coronary artery. Aizawa Y; Murata M; Hayashi M; Funazaki T; Ito S; Shibata A Jpn Circ J; 1985 Jun; 49(6):584-8. PubMed ID: 3839860 [TBL] [Abstract][Full Text] [Related]
15. Influence of inhibition of endothelium-derived nitric oxide formation to effects of vasoconstrictor agents neuropeptide Y, clonidine, and ergonovine on coronary vascular resistance. Tsunoda R; Okumura K; Ishizaka H; Matsunaga T; Yasue H J Cardiovasc Pharmacol; 1994 Jul; 24(1):87-94. PubMed ID: 7521496 [TBL] [Abstract][Full Text] [Related]
16. Intense sympathetic stimulation releases neuropeptide Y but fails to evoke sustained coronary vasoconstriction in dogs. Otani N; Yang T; Levy MN Circ Res; 1993 Apr; 72(4):816-26. PubMed ID: 8443869 [TBL] [Abstract][Full Text] [Related]
17. Transmural regulation of myocardial perfusion by neuropeptide Y. Gutterman DD; Morgan DA Basic Res Cardiol; 1995; 90(4):348-55. PubMed ID: 8534260 [TBL] [Abstract][Full Text] [Related]
18. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle. Ekelund U; Erlinge D Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740 [TBL] [Abstract][Full Text] [Related]
19. Interference of angiotensin-converting enzyme inhibition with vasoactive peptides in the coronary circulation of dogs. Bauer B; Neubauer S; Spindler M; Dürr R; Becker HH; Ertl G J Cardiovasc Pharmacol; 1995 May; 25(5):756-62. PubMed ID: 7630154 [TBL] [Abstract][Full Text] [Related]
20. Leukotriene D4-induced vasoconstriction of coronary arteries in anaesthetized dogs. Fiedler VB; Mardin M; Abram TS Eur Heart J; 1984 Mar; 5(3):253-60. PubMed ID: 6723695 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]